Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Genetics of mineralocorticoid excess: an update for clinicians.

Zennaro MC, Rickard AJ, Boulkroun S.

Eur J Endocrinol. 2013 Jun 1;169(1):R15-25. doi: 10.1530/EJE-12-0813. Print 2013 Jul. Review.

2.

Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.

Williams TA, Monticone S, Schack VR, Stindl J, Burrello J, Buffolo F, Annaratone L, Castellano I, Beuschlein F, Reincke M, Lucatello B, Ronconi V, Fallo F, Bernini G, Maccario M, Giacchetti G, Veglio F, Warth R, Vilsen B, Mulatero P.

Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.

3.

An update on novel mechanisms of primary aldosteronism.

Zennaro MC, Boulkroun S, Fernandes-Rosa F.

J Endocrinol. 2015 Feb;224(2):R63-77. doi: 10.1530/JOE-14-0597. Epub 2014 Nov 25. Review.

4.

Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.

Fernandes-Rosa FL, Giscos-Douriez I, Amar L, Gomez-Sanchez CE, Meatchi T, Boulkroun S, Zennaro MC.

Hypertension. 2015 Nov;66(5):1014-22. doi: 10.1161/HYPERTENSIONAHA.115.05993. Epub 2015 Sep 8.

5.

Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.

Fernandes-Rosa FL, Williams TA, Riester A, Steichen O, Beuschlein F, Boulkroun S, Strom TM, Monticone S, Amar L, Meatchi T, Mantero F, Cicala MV, Quinkler M, Fallo F, Allolio B, Bernini G, Maccario M, Giacchetti G, Jeunemaitre X, Mulatero P, Reincke M, Zennaro MC.

Hypertension. 2014 Aug;64(2):354-61. doi: 10.1161/HYPERTENSIONAHA.114.03419. Epub 2014 May 27.

6.

Ins and outs of aldosterone-producing adenomas of the adrenal: from channelopathy to common curable cause of hypertension.

Brown MJ.

Hypertension. 2014 Jan;63(1):24-6. doi: 10.1161/HYPERTENSIONAHA.113.01833. Epub 2013 Sep 30. No abstract available.

7.

Genetics of primary aldosteronism.

Funder JW.

Front Horm Res. 2014;43:70-8. doi: 10.1159/000360870. Epub 2014 Jun 10.

PMID:
24943299
8.

Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

Monticone S, Castellano I, Versace K, Lucatello B, Veglio F, Gomez-Sanchez CE, Williams TA, Mulatero P.

Mol Cell Endocrinol. 2015 Aug 15;411:146-54. doi: 10.1016/j.mce.2015.04.022. Epub 2015 May 6.

9.

Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.

Oßwald A, Fischer E, Degenhart C, Quinkler M, Bidlingmaier M, Pallauf A, Lang K, Mussack T, Hallfeldt K, Beuschlein F, Reincke M.

Eur J Endocrinol. 2013 Oct 1;169(5):657-63. doi: 10.1530/EJE-13-0551. Print 2013 Nov.

10.

[Primary aldosteronism: new insights into familial forms].

van den Meiracker AH, van der Linde AA, Claahsen van der Grinten HL, Danser AH, Deinum J.

Ned Tijdschr Geneeskd. 2015;159:A8932. Review. Dutch.

PMID:
26420144
11.

SY 03-3 OVERVIEW OF SOMATIC MUTATIONS AND EPIGENETIC REGULATION OF ALDOSTERONE PRODUCING ADENOMA (APA).

Umemura S.

J Hypertens. 2016 Sep;34 Suppl 1 - ISH 2016 Abstract Book:e14-e15.

PMID:
27753830
12.

Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.

Dutta RK, Welander J, Brauckhoff M, Walz M, Alesina P, Arnesen T, Söderkvist P, Gimm O.

Endocr Relat Cancer. 2014 Jan 8;21(1):L1-4. doi: 10.1530/ERC-13-0466. Print 2014 Feb. No abstract available.

13.

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP.

Science. 2011 Feb 11;331(6018):768-72. doi: 10.1126/science.1198785.

14.

Novel genes in primary aldosteronism.

Fischer E, Beuschlein F.

Curr Opin Endocrinol Diabetes Obes. 2014 Jun;21(3):154-8. doi: 10.1097/MED.0000000000000060. Review.

PMID:
24739312
15.

[Genetic alterations in primary aldosteronism].

Zennaro MC, Fernandes-Rosa F, Boulkroun S.

Med Sci (Paris). 2015 Apr;31(4):389-96. doi: 10.1051/medsci/20153104013. Epub 2015 May 8. Review. French.

16.

Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.

Zheng FF, Zhu LM, Nie AF, Li XY, Lin JR, Zhang K, Chen J, Zhou WL, Shen ZJ, Zhu YC, Wang JG, Zhu DL, Gao PJ.

Hypertension. 2015 Mar;65(3):622-8. doi: 10.1161/HYPERTENSIONAHA.114.03346. Epub 2015 Jan 26.

17.

Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.

Åkerström T, Willenberg HS, Cupisti K, Ip J, Backman S, Moser A, Maharjan R, Robinson B, Iwen KA, Dralle H, D Volpe C, Bäckdahl M, Botling J, Stålberg P, Westin G, Walz MK, Lehnert H, Sidhu S, Zedenius J, Björklund P, Hellman P.

Endocr Relat Cancer. 2015 Oct;22(5):735-44. doi: 10.1530/ERC-15-0321.

18.

New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.

Scholl UI, Lifton RP.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):141-7. doi: 10.1097/MNH.0b013e32835cecf8. Review.

PMID:
23318698
19.

A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management.

Raizman JE, Diamandis EP, Holmes D, Stowasser M, Auchus R, Cavalier E.

Clin Chem. 2015 Aug;61(8):1022-7. doi: 10.1373/clinchem.2015.242990. Epub 2015 Jun 23. No abstract available.

20.

Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.

Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, Morimoto R, Nozawa Y, Gomez-Sanchez CE, Tomlins SA, Rainey WE, Ito S, Satoh F, Sasano H.

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1182-1192. doi: 10.1210/jc.2016-2986.

PMID:
28388725

Supplemental Content

Support Center